Investment Stage

Focus Areas

About Investor

Victor Evian is an investment manager in the BioMedTech team at Truffle Capital. Truffle Capital focuses on life sciences, medtech, biotech, fintech, and insurtech, invests at Seed and Series A, and lists a first ticket size of €1,000,000 - €35,000,000. He joined the firm in March 2024 as an analyst and was promoted to investment manager in 2025. Evian trained as a biomechanics engineer at EPFL, completed a double degree in management, technology, and entrepreneurship, wrote his master’s thesis at Harvard Medical School and Spaulding Rehabilitation, and previously worked in healthcare investing at Crédit Mutuel Innovation and Newfund.